Abstract：Radio-frequency ablation has been widely used in renal carcinoma, especially in small renal masses. This paper presented a review of radio-frequency ablation in its theory, indications, standard of success and oncology effect.
[1]Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol, 1997, 11: 251-258. [2]Cutress ML, Ratan HL, Williams ST, et al. Update on the management of T1 renal cortical tumours. BJU Int, 2010, 106(8): 1130-1136. [3]Johnson DB, Cadeddu JA. Radiofrequency interstitial tumor ablation: dry electrode. J Endourol, 2003, 17: 557-562. [4]Hsu TH, Fidler ME, Gill IS. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology, 2000, 56: 872-875. [5]Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol, 2000, 174: 323-331. [6]Margulis V, Matsumoto ED, Lindberg G, et al. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology, 2004, 64: 660-663. [7]Gupta A, Raman JD, Leveillee RJ, et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol, 2009, 23: 1099-1105. [8]Aron M, Gill IS. Renal tumor ablation. Curr Opin Urol, 2005, 15: 298-305. [9]Graversen JA, Mues AC, Landman J. Laparoscopic ablation of renal neoplasms. J Endourol, 2011, 25: 187-194. [10]Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int, 2007, 100: 287-290. [11]连惠波, 郭宏骞, 甘卫东, 等. 腹腔镜下冷循环射频消融和肾部分切除术治疗肾癌的临床疗效比较. 中华泌尿外科杂志, 2009, 30: 731-734. [12]Faddegon S, Cadeddu JA. Does Renal Mass Ablation Provide Adequate Long-term Oncologic Control? Urol Clin North Am, 2012, 39: 181-190. [13]Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol, 2006, 176: 1973-1977. [14]Rutherford EE, Cast JE, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol, 2008, 63: 220-230. [15]Meloni MF, Bertolotto M, Alberzoni C, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol, 2008, 191: 1233-1238. [16]Matsumoto ED, Watumull L, Johnson DB, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol, 2004, 172: 45-48. [17]Kaouk JH, Aron M, Rewcastle JC, et al. Cryotherapy: clinical end points and their experimental foundations. Urology, 2006, 68: 38-44. [18]Wile GE, Leyendecker JR, Krehbiel KA, et al. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics, 2007, 27: 325-339. [19]Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation: outcome at 3 years. J Urol, 2005, 173: 1903-1907. [20]徐向军, 纪长威, 屈峰, 等. 螺旋 CT 评估射频消融治疗肾癌的疗效. 中国医学影像技术, 2011, 27: 167-170. [21]Marcovich R, Aldana JP, Morgenstern N, et al. Optimal lesion assessment following acute radio frequency ablation of porcine kidney: cellular viability or histopathology? J Urol, 2003, 170: 1370-1374. [22]Raman JD, Stern JM, Zeltser I, et al. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol, 2008, 179: 2142-2145. [23]Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol, 2008, 180: 499-504. [24]McDougal WS, Gervais DA, McGovern FJ, et al. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol, 2005, 174: 61-63. [25]Tracy CR, Raman JD, Donnally C, et al. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer, 2010, 116: 3135-3142. [26]Ferakis N, Bouropoulos C, Granitsas T, et al. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol, 2010, 24: 1909-1913. [27]Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol, 2009, 182: 1271-1279. [28]Zagoria RJ, Traver MA, Werle DM, et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol, 2007, 189: 429-436. [29]Turna B, Kaouk JH, Frota R, et al. Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol, 2009, 182: 2150-2157. [30]Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer, 2008, 113: 2671-2680. [31]Takaki H, Yamakado K, Soga N, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol, 2010, 28: 460-468. [32]Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol, 2008, 179: 1227-1233. [33]Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol, 2004, 172: 874-877. [34]Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol, 2001, 166: 6-18. [35]Ramani AP, Desai MM, Steinberg AP, et al. Complications of laparoscopic partial nephrectomy in 200 cases. J Urol, 2005, 173: 42-47.
